Market News & Trends
Nuclera & leadXpro Partner to Accelerate Structure-Based Drug Design for Complex Membrane Proteins
Nuclera and leadXpro recently announced a scientific partnership. The collaboration brings together eProtein Discovery’s rapid multiplex membrane protein screening with leadXpro’s AI/ML-driven construct design and…
Deciphera Pharmaceuticals Announces US FDA Acceptance for Filing of NDA for Tirabrutinib in Patients With Relapsed or Refractory PCNSL
Deciphera Pharmaceuticals recently announced the US FDA has accepted for filing the New Drug Application (NDA) under the accelerated approval pathway for tirabrutinib, a highly…
Capricorn Scientific Expands European Infrastructure to Drive Scalable Biotech & Pharma Growth
Capricorn Scientific is expanding its European footprint with a new 4,000 m² logistics and infrastructure hub in Ebsdorfergrund, Germany - designed to strengthen supply security,…
Cyrano Therapeutics Announces Positive Topline Results of a Proprietary & Potential First-to-Market Regenerative Therapy for Persistent Smell Loss
Cyrano Therapeutics, Inc. recently announced positive topline results from its Phase 2 FLAVOR trial of CYR-064, an innovative, intranasal soft-mist spray for the treatment of persistent…
Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer’s Disease
Annovis Bio, Inc. recently announced an independent Data and Safety Monitoring Board (DSMB) has issued a positive recommendation regarding the safety of buntanetap at 6…
Rottendorf Pharma & Corealis Pharma Offer Seamless OSD Development & Manufacturing
Rottendorf Pharma and Corealis Pharma have expanded their service offering through a strategic partnership. The collaboration offers pharmaceutical and biotech companies a strategic transatlantic alliance…
Sirio Pharma to Introduce First-in-Market Lutein Soft Chew for Eye Health
Sirio Pharma has collaborated with prominent science-backed ingredient provider OmniActive Health Technologies (OmniActive) to launch a first-in-market soft chew lutein supplement. Featuring OmniActive’s award-winning Lutemax…
Thermo Fisher Scientific Expands Real-World Data Interoperability & Linkage Through Strategic Collaboration With Datavant
Thermo Fisher Scientific recently announced a strategic data collaboration with Datavant, the data collaboration platform trusted for healthcare, to make it easier for pharmaceutical and…
Calla Lily Clinical Care & Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform
Calla Lily Clinical Care and Merck have entered a strategic collaboration to support the continued development of Callavid®, a novel platform for intravaginal drug delivery.…
Eliquis Sales to Fall as European Patent Expiry Nears
Global sales of Bristol Myers Squibb’s (BMS) and Pfizer’s drug Eliquis (apixaban) are projected to decline by 15.2% in 2026 due to the loss of…
MIMETAS & Partners Launch World’s First Microphysiological Systems Industry Alliance
Today marks an important step for the global microphysiological systems (MPS) field with the launch of IAMPS – the Industry Alliance for Microphysiological Systems –…
Evogene Announces Expanded Collaboration With Google Cloud to Integrate AI Agents Into ChemPass AI
Evogene Ltd. recently announced an expanded phase of its collaboration with Google Cloud. Under this new phase, the collaboration will focus on developing and integrating…
Synthace Collaborates With Charles River to Offer Global Pharma Industry More Robust, Faster & Cost-Effective Assays
Synthace recently announced a collaboration with Charles River Laboratories International, Inc. Under the collaboration, Charles River will give its clients access to Synthace’s transformative approach to…
SPT Labtech & BellBrook Labs Introduce High-Throughput Screening Platform for Cancer Research
SPT Labtech and BellBrook Labs recently announced a collaboration to advance cancer research. Together, the companies have developed a miniaturized, high-throughput screening platform for the…
Sobi Completes Acquisition of Arthrosi Therapeutics, Strengthening Pipeline Potential Treatment of Gout
Swedish Orphan Biovitrum AB (publ) Sobi and Arthrosi Therapeutics, Inc. recently announced the completion of the acquisition of Arthrosi by Sobi. Upon completion of the…
Evinova & Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development With Artificial Intelligence
Evinova recently announced Bristol Myers Squibb has signed an agreement to optimize clinical trials with Evinova’s AI-native clinical development platform. Under the terms of the…
NeoVac Announces Positive Results Demonstrating Superior Safety Profile of Next-Generation mRNA-LNP Vaccine Platform
NeoVac recently announced positive results from first-in-human Phase I/II clinical study of NeomiVac, its investigational mRNA-LNP COVID-19 vaccine candidate. The clinical findings, now publicly available as…
SynGenSys Introduces Liver.SET Synthetic Promoter Library for Liver-Specific Gene Expression for In Vivo Gene Therapies
SynGenSys recently announced the launch of its Liver.SET library of liver-specific synthetic promoters. Developed using SyngenSys’ proprietary informatics and computational design platform, the Liver.SET library…
Evogene & Shanghai Lishan Biopharmaceuticals Announce Exclusive Licensing Agreement for a Microbiome-Based Therapeutic for Renal & Lung Cancer
Evogene Ltd. and Shanghai Lishan Biopharmaceuticals Co., Ltd. recently announced that Biomica Ltd., Evogene’s subsidiary, and Lishan Biotech entered into an exclusive worldwide licensing agreement for…
Coherus Oncology Announces Clinical Supply Agreement to Evaluate Tagmokitug in Combination With Pasritamig
Coherus Oncology, Inc. recently announced a clinical supply agreement with Johnson & Johnson to evaluate tagmokitug (CHS-114), Coherus Oncology’s investigational anti-CCR8 cytolytic monoclonal antibody, in…
